Viewing nowCombinationOrosartan 5/160mg Tablets
Valsartan 160mg · Amlodipine Orotate 6.91mg
Tablet · Prescription medication · Combination
Dong-A ST Co., Ltd.

MFDS item code 201308526 · Approved 2013.07.30 · Insurance code 642506980
Treatment of essential hypertension not controlled with monotherapy
This drug is used to control blood pressure in patients with essential hypertension who are not adequately controlled with either amlodipine or valsartan alone.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication can cause serious harm to the fetus and newborn if used during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with an allergy to any of the major ingredients of this medication, in pregnant or breastfeeding women, or in patients with severe kidney or liver disorders. Patients with low sodium or fluid levels in the body should manage their condition before taking this medication, and should monitor blood pressure and their condition carefully while taking it. Patients with hyperkalemia should have their potassium levels frequently checked when taking this medication together with potassium supplements, as potassium levels can become dangerously high. Patients with renal vascular issues or those who have had a kidney transplant should also monitor kidney function closely when taking this medication. This medication may cause an allergic reaction known as angioedema, so if there are symptoms of swelling in the face, lips, or tongue, they should stop taking it immediately. Patients after heart failure or myocardial infarction should frequently check kidney function and blood pressure when taking this medication and be alert to the possibility of side effects, such as pulmonary edema. This medication can interact with other blood pressure medications, diuretics, potassium-sparing agents, and non-steroidal anti-inflammatory drugs (NSAIDs), so it is essential to inform healthcare providers of any other medications being taken. Caution is needed as dizziness or fatigue may occur when driving or operating machinery. In cases of overdose, severe hypotension or reflex tachycardia may occur, requiring immediate medical intervention. It can be safely used in the elderly at standard dosing, but caution is advised based on their physical condition. Safety and efficacy in pediatric patients have not been sufficiently established, and its use is not recommended. It is important to regularly monitor blood pressure, kidney function, and potassium levels during treatment with this medication to ensure there are no abnormalities.
Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, orthostatic dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, itching, joint swelling, back pain, arthritis, muscle cramps, lethargy, pollakiuria, polyuria, erectile dysfunction, edema, dependent edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, vesicular dermatitis, myalgia, renal failure, kidney injury, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, dysgeusia, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorders, nocturia, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux, neck pain, hypercholesterolemia, hypoglycemia, neurogenic irritation, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and should be kept at a temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the medication's efficacy.
Dark yellow oval film-coated tablets
30 tablets/PTP, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Orotate 6.91mg
Tablet · Prescription medication · Combination
Dong-A ST Co., Ltd.
CombinationValsartan 160mg · Amlodipine Orotate 13.82mg
Tablet · Prescription medication · Combination
Dong-A ST Co., Ltd.
CombinationValsartan 80mg · Amlodipine Orotate 6.91mg
Tablet · Prescription medication · Combination
Dong-A ST Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.